Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Hai Dong, Chi"'
Autor:
Qing Yuan Zhang, Tao Sun, Yong Mei Yin, Hui Ping Li, Min Yan, Zhong Sheng Tong, Christina P. Oppermann, Yun Peng Liu, Romulo Costa, Man Li, Ying Cheng, Qu Chang Ouyang, Xi Chen, Ning Liao, Xin Hong Wu, Xiao Jia Wang, Ji Feng Feng, Roberto Hegg, G.B. Kanakasetty, Maria A. Coccia-Portugal, Ru Bing Han, Yi Lu, Hai Dong Chi, Ze Fei Jiang, Xi Chun Hu
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Aim: To compare the efficacy, safety, and tolerability of abemaciclib plus endocrine therapy (ET) versus ET alone in postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast ca
Externí odkaz:
https://doaj.org/article/97a1aeef27ca442790bae5374547f9e7
Autor:
Xin Hong Wu, Hai Dong Chi, Ying Cheng, Min Yan, Zhong Sheng Tong, Hui Ping Li, Ze Fei Jiang, Yi Lu, Man Li, Xi Chen, Tao Sun, Qu Chang Ouyang, Ning Liao, G.B. Kanakasetty, Yong Mei Yin, Yunpeng Liu, Xi Chun Hu, Roberto Hegg, Xiao Jia Wang, Ru Bing Han, Ji Feng Feng, Maria A. Coccia-Portugal, Romulo Costa, Christina Pimentel Oppermann, Q. Zhang
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology
Aim:To compare the efficacy, safety, and tolerability of abemaciclib plus endocrine therapy (ET) versus ET alone in postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast can
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 10:330-339
Aims The incidence of breast cancer in China is increasing at a rate greater than the global average. For treatment of metastatic breast cancer, a phase 3 trial of 529 patients (study JHQG) found that the combination of gemcitabine, a cytotoxic nucle
Publikováno v:
Advanced Materials Research. :582-586
The indoor communications is a new market in the future. This Article introduces one data transmission system based with OFDM signals. The overview of the communication system and synchronization theory background will be introduced. The simulation r
Autor:
Hai Dong Chi, Li Wang, Alka Preston, Anne-Marie Martin, Daniel Chua, Shi Ying Yu, Rong Cheng Luo, Zhi Min Shao, B. Newstat, Dong Geng Liu, Winnie Yeo, Bing He Xu, Xiao Ji Wang, Ze Fei Jiang
Publikováno v:
Chinese Journal of Cancer
Overexpression of human epidermal growth factor receptor-2 (HER2) in metastatic breast cancer (MBC) is associated with poor prognosis. This single-arm open-label trial (EGF109491; NCT00508274) was designed to confirm the efficacy and safety of lapati
Autor:
Binghe, Xu, Xiao Qing, Zhang, Hai Dong, Chi, Zhixin, Liu, Mitchell, Quinlivan, Mauro, Orlando
Publikováno v:
Asia-Pacific journal of clinical oncology. 10(4)
The incidence of breast cancer in China is increasing at a rate greater than the global average. For treatment of metastatic breast cancer, a phase 3 trial of 529 patients (study JHQG) found that the combination of gemcitabine, a cytotoxic nucleoside
Autor:
Xu, Binghe1, Zhang, Xiao Qing2, Chi, Hai Dong2, Liu, Zhixin3, Quinlivan, Mitchell3, Orlando, Mauro4
Publikováno v:
Asia Pacific Journal of Clinical Oncology. Dec2014, Vol. 10 Issue 4, p330-339. 10p.
Autor:
Zhang, Qing Yuan, Sun, Tao, Yin, Yong Mei, Li, Hui Ping, Yan, Min, Tong, Zhong Sheng, Oppermann, Christina P., Liu, Yun Peng, Costa, Romulo, Li, Man, Cheng, Ying, Ouyang, Qu Chang, Chen, Xi, Liao, Ning, Wu, Xin Hong, Wang, Xiao Jia, Feng, Ji Feng, Hegg, Roberto, Kanakasetty, G.B., Coccia-Portugal, Maria A.
Publikováno v:
Therapeutic Advances in Medical Oncology; 10/22/2020, p1-14, 14p
Autor:
Zhang, Qing Yuan, Sun, Tao, Yin, Yong Mei, Li, Hui Ping, Yan, Min, Tong, Zhong Sheng, Oppermann, Christina P., Liu, Yun Peng, Romulo Costa, Li, Man, Cheng, Ying, Ouyang, Qu Chang, Chen, Xi, Liao, Ning, Wu, Xin Hong, Wang, Xiao Jia, Feng, Ji Feng, Hegg, Roberto, G.B. Kanakasetty, Coccia-Portugal, Maria A., Han, Ru Bing, Lu, Yi, Chi, Hai Dong, Jiang, Ze Fei, Hu, Xi Chun
Supplemental material, MONARCH_plus_supplement_27Jul20 for MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study by Qing Yuan Zhang, Tao Sun, Yong Mei Yin, Hui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c70acdad6615137925071e2cbe048f8
Autor:
Edwin Moise
On July 31, the U.S. Navy destroyer USS Maddox (DD-731) began a reconnaissance cruise off the coast of North Vietnam. On August 2, three North Vietnamese torpedo boats attacked the ship. On the night of August 4, the Maddox and another destroyer, the